Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Diclofenac | The risk or severity of adverse effects can be increased when Diclofenac is combined with Pranoprofen. |
| Flurbiprofen | The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Pranoprofen. |
| Bromfenac | The risk or severity of adverse effects can be increased when Bromfenac is combined with Pranoprofen. |
| Nepafenac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Pranoprofen. |
| Indomethacin | The risk or severity of adverse effects can be increased when Indomethacin is combined with Pranoprofen. |
| Nabumetone | The risk or severity of adverse effects can be increased when Nabumetone is combined with Pranoprofen. |
| Tenoxicam | The risk or severity of adverse effects can be increased when Tenoxicam is combined with Pranoprofen. |
| Celecoxib | The risk or severity of adverse effects can be increased when Celecoxib is combined with Pranoprofen. |
| Tolmetin | The risk or severity of adverse effects can be increased when Tolmetin is combined with Pranoprofen. |
| Rofecoxib | The risk or severity of adverse effects can be increased when Rofecoxib is combined with Pranoprofen. |
| Piroxicam | The risk or severity of adverse effects can be increased when Piroxicam is combined with Pranoprofen. |
| Fenoprofen | The risk or severity of adverse effects can be increased when Fenoprofen is combined with Pranoprofen. |
| Valdecoxib | The risk or severity of adverse effects can be increased when Valdecoxib is combined with Pranoprofen. |
| Sulindac | The risk or severity of adverse effects can be increased when Sulindac is combined with Pranoprofen. |
| Etodolac | The risk or severity of adverse effects can be increased when Etodolac is combined with Pranoprofen. |
| Mefenamic acid | The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Pranoprofen. |
| Naproxen | The risk or severity of adverse effects can be increased when Naproxen is combined with Pranoprofen. |
| Sulfasalazine | The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pranoprofen. |
| Phenylbutazone | The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Pranoprofen. |
| Meloxicam | The risk or severity of adverse effects can be increased when Meloxicam is combined with Pranoprofen. |
| Carprofen | The risk or severity of adverse effects can be increased when Carprofen is combined with Pranoprofen. |
| Diflunisal | The risk or severity of adverse effects can be increased when Diflunisal is combined with Pranoprofen. |
| Suprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Pranoprofen. |
| Salicylic acid | The risk or severity of adverse effects can be increased when Salicylic acid is combined with Pranoprofen. |
| Meclofenamic acid | The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pranoprofen. |
| Oxaprozin | The risk or severity of adverse effects can be increased when Oxaprozin is combined with Pranoprofen. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Pranoprofen. |
| Balsalazide | The risk or severity of adverse effects can be increased when Balsalazide is combined with Pranoprofen. |
| Ibuprofen | The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pranoprofen. |
| Olsalazine | The risk or severity of nephrotoxicity can be increased when Pranoprofen is combined with Olsalazine. |
| Lumiracoxib | The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Pranoprofen. |
| Magnesium salicylate | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Pranoprofen. |
| Salsalate | The risk or severity of adverse effects can be increased when Salsalate is combined with Pranoprofen. |
| Choline magnesium trisalicylate | The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pranoprofen. |
| Antipyrine | The risk or severity of adverse effects can be increased when Antipyrine is combined with Pranoprofen. |
| Tiaprofenic acid | The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Pranoprofen. |
| Etoricoxib | The risk or severity of adverse effects can be increased when Etoricoxib is combined with Pranoprofen. |
| Oxyphenbutazone | The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Pranoprofen. |
| Niflumic acid | The risk or severity of adverse effects can be increased when Niflumic acid is combined with Pranoprofen. |
| Benoxaprofen | The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Pranoprofen. |
| Zomepirac | The risk or severity of adverse effects can be increased when Zomepirac is combined with Pranoprofen. |
| Lornoxicam | The risk or severity of adverse effects can be increased when Lornoxicam is combined with Pranoprofen. |
| Aceclofenac | The risk or severity of adverse effects can be increased when Aceclofenac is combined with Pranoprofen. |
| Zaltoprofen | The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Pranoprofen. |
| Azapropazone | The risk or severity of adverse effects can be increased when Azapropazone is combined with Pranoprofen. |
| Felbinac | The risk or severity of adverse effects can be increased when Felbinac is combined with Pranoprofen. |
| Parecoxib | The risk or severity of adverse effects can be increased when Parecoxib is combined with Pranoprofen. |
| Salicylamide | The risk or severity of adverse effects can be increased when Salicylamide is combined with Pranoprofen. |
| Kebuzone | The risk or severity of adverse effects can be increased when Kebuzone is combined with Pranoprofen. |
| Isoxicam | The risk or severity of adverse effects can be increased when Isoxicam is combined with Pranoprofen. |
| Indoprofen | The risk or severity of adverse effects can be increased when Indoprofen is combined with Pranoprofen. |
| Ibuproxam | The risk or severity of adverse effects can be increased when Ibuproxam is combined with Pranoprofen. |
| Floctafenine | The risk or severity of adverse effects can be increased when Floctafenine is combined with Pranoprofen. |
| Fenbufen | The risk or severity of adverse effects can be increased when Fenbufen is combined with Pranoprofen. |
| Etofenamate | The risk or severity of adverse effects can be increased when Etofenamate is combined with Pranoprofen. |
| Epirizole | The risk or severity of adverse effects can be increased when Epirizole is combined with Pranoprofen. |
| Loxoprofen | The risk or severity of adverse effects can be increased when Loxoprofen is combined with Pranoprofen. |
| Droxicam | The risk or severity of adverse effects can be increased when Droxicam is combined with Pranoprofen. |
| Tolfenamic acid | The risk or severity of adverse effects can be increased when Tolfenamic acid is combined with Pranoprofen. |
| Clonixin | The risk or severity of adverse effects can be increased when Clonixin is combined with Pranoprofen. |
| Tepoxalin | The risk or severity of adverse effects can be increased when Tepoxalin is combined with Pranoprofen. |
| Flunixin | The risk or severity of adverse effects can be increased when Flunixin is combined with Pranoprofen. |
| Tinoridine | The risk or severity of adverse effects can be increased when Tinoridine is combined with Pranoprofen. |
| Alclofenac | The risk or severity of adverse effects can be increased when Alclofenac is combined with Pranoprofen. |
| Fentiazac | The risk or severity of adverse effects can be increased when Fentiazac is combined with Pranoprofen. |
| Suxibuzone | The risk or severity of adverse effects can be increased when Suxibuzone is combined with Pranoprofen. |
| Bumadizone | The risk or severity of adverse effects can be increased when Bumadizone is combined with Pranoprofen. |
| Alminoprofen | The risk or severity of adverse effects can be increased when Alminoprofen is combined with Pranoprofen. |
| Bufexamac | The risk or severity of adverse effects can be increased when Bufexamac is combined with Pranoprofen. |
| Feprazone | The risk or severity of adverse effects can be increased when Feprazone is combined with Pranoprofen. |
| Difenpiramide | The risk or severity of adverse effects can be increased when Difenpiramide is combined with Pranoprofen. |
| Nifenazone | The risk or severity of adverse effects can be increased when Nifenazone is combined with Pranoprofen. |
| Lonazolac | The risk or severity of adverse effects can be increased when Lonazolac is combined with Pranoprofen. |
| Tenidap | The risk or severity of adverse effects can be increased when Tenidap is combined with Pranoprofen. |
| Bendazac | The risk or severity of adverse effects can be increased when Bendazac is combined with Pranoprofen. |
| Propyphenazone | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Propyphenazone. |
| Proglumetacin | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Proglumetacin. |
| Guacetisal | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Guacetisal. |
| Ethenzamide | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Ethenzamide. |
| Carbaspirin calcium | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Carbaspirin calcium. |
| Mofebutazone | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Mofebutazone. |
| Proquazone | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Proquazone. |
| Benorilate | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Benorilate. |
| Pirprofen | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Pirprofen. |
| Acemetacin | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Acemetacin. |
| Imidazole salicylate | The risk or severity of adverse effects can be increased when Pranoprofen is combined with Imidazole salicylate. |
| Benzydamine | The risk or severity of adverse effects can be increased when Benzydamine is combined with Pranoprofen. |
| Icosapent | The risk or severity of adverse effects can be increased when Icosapent is combined with Pranoprofen. |
| Antrafenine | The risk or severity of adverse effects can be increased when Antrafenine is combined with Pranoprofen. |
| Dexibuprofen | The risk or severity of adverse effects can be increased when Dexibuprofen is combined with Pranoprofen. |
| Trolamine salicylate | The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Pranoprofen. |
| Cimicoxib | The risk or severity of adverse effects can be increased when Cimicoxib is combined with Pranoprofen. |
| Robenacoxib | The risk or severity of adverse effects can be increased when Robenacoxib is combined with Pranoprofen. |
| Aminophenazone | The risk or severity of adverse effects can be increased when Aminophenazone is combined with Pranoprofen. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Pranoprofen. |
| SC-236 | The risk or severity of adverse effects can be increased when Pranoprofen is combined with SC-236. |
| NS-398 | The risk or severity of adverse effects can be increased when Pranoprofen is combined with NS-398. |
| Firocoxib | The risk or severity of adverse effects can be increased when Firocoxib is combined with Pranoprofen. |
| Morniflumate | The risk or severity of adverse effects can be increased when Morniflumate is combined with Pranoprofen. |
| Talniflumate | The risk or severity of adverse effects can be increased when Talniflumate is combined with Pranoprofen. |